CLOMIPHENE CITRATE MARKET ANALYSIS (2020-2027)

1

• Coherent Market Insights
• Market Research and Business Consulting Services
• https//www.coherentmarketinsights.com/
• COVID-19 Impact Tracker

2
CLOMIPHENE CITRATE MARKET ANALYSIS (2020-2027)

• Clomiphene Citrate Market, by Indication (PCOS,
  Secondary Amenorrhea, Psychogenic Amenorrhea,
  Amenorrhea Galactorrhea Syndrome, and Others), by
  Distribution Channel (Hospital Pharmacies, Retail
  Pharmacies, and Online Pharmacies), and by Region
  (North America, Latin America, Europe, Asia
  Pacific, Middle East, and Africa) - Size, Share,
  Outlook, and Opportunity Analysis, 2020 - 2027

3
CLOMIPHENE CITRATE MARKET ANALYSIS (2020-2027)

• Clomiphene citrate is an oral medication that is
  often used to treat certain types of female
  infertility. Infertility is a global health
  issue, as its affects both men and women.
  Infertility in females could be due to increasing
  age, polycystic ovarian syndrome (PCOS), obesity,
  and multiple miscarriages.

4

• Clomiphene citrate works by stimulating an
  increase in the amount of hormones that support
  the growth and release of a mature egg
  (ovulation). This medication is not recommended
  for women whose ovaries no longer make eggs
  properly (primary pituitary or ovarian failure).
  Other names of clomiphene citrate are Clomid,
  Clomifene, Chloramifene, and Chloramiphene. It is
  also used for the treatment of polycystic ovary
  syndrome (PCOS), secondary amenorrhea,
  psychogenic amenorrhea, amenorrhea galactorrhea
  syndrome, and others. It is taken as a 50 mg pill
  that is usually taken for five days in a row in
  the beginning of a womans menstrual cycle.

5

• Clomiphene Citrate Market - Impact of Coronavirus
  (Covid-19) Pandemic
• The COVID-19 pandemic has significantly hampered
  demand for clomiphene citrate because the women
  who are under treatment of clomiphene citrate for
  infertility or PCOS, tests positive for COVID-19
  infection, they must suspend the clomiphene
  citrate treatment and other fertility treatment
  alongside, as per the American Society for
  Reproductive Medicine (ASRM). However, according
  to the American Society for Reproductive Medicine
  data of March 2020, there are reports of women
  who have tested positive for COVID-19 delivering
  babies free of the COVID-19 infection. The
  coronavirus is not a fatal infection for a
  pregnant women.
• The clomiphene citrate market is estimated to be
  valued at US 10.02 million in 2020 and is
  expected to exhibit a CAGR of 5.4 during the
  forecast period (2020-2027).

6

• Figure 1 Clomiphene Citrate Market Share ()
  Analysis, By Indication, 2020

7

• The increasing rate of infertility is expected to
  drive growth of the clomiphene citrate market
• Infertility is a health issue that affects both
  men and women, worldwide. Increasing infertility
  rates is expected to propel global demand for
  clomiphene citrate over the forecast period. For
  instance, according to the Centers for Disease
  Control and Prevention (CDC) report of 2018,
  around 6 of women aged 15 to 44 years in the
  U.S. were unable to conceive after one year of
  continuous intercourse. Furthermore, around 12
  of women aged 15 to 44 years in the U.S. had
  difficulty in conceiving or carrying a pregnancy
  till child birth in 2017. Infertility also
  affects men. According to the same source, around
  9 of men aged 25 to 44 years in the U.S.
  reported that they required medical help for
  reproduction in 2017. Clomiphene is used to treat
  infertility in both men and women. The U.S. FDA
  approved clomiphene citrate for women infertility
  in 1960s whereas, its often prescribed off-label
  for treatment of male infertility.

8

• Clomiphene Citrate Market Restraints
• The clomiphene citrate market is expected to be
  negatively affected, owing to clomiphene
  citrates inefficiency in terms of being a less
  effective treatment to achieve pregnancy and live
  child births when compared to other medicines
  such as Letrozole. For instance, in 2014, a team
  of researchers at National Institutes of Healths
  (NIH) Eunice Kennedy Shriver National Institute
  of Child Health and Human Development (NICHD)
  found that women treated with Letrozole showed
  high rate of ovulation and live births than women
  treated with the standard drug, clomiphene
  citrate. Furthermore, as per the same source,
  among women who received Letrozole, 27.5 of them
  eventually had a live birth and among women who
  received clomiphene, only 19.1 of them
  experienced a live child birth. The cumulative
  ovulation rate was higher for Letrozole group,
  with ovulation occurring 61.7 of the time and
  the women in the clomiphene group ovulated 48.3
  of the time.

9
(No Transcript)
10

• Clomiphene Citrate Market Regional Analysis
• The North America clomiphene citrate market is
  expected to hold a dominant position in the
  global clomiphene citrate market, owing to the
  high prevalence of polycystic ovary syndrome
  (PCOS) in the U.S. For instance, according to the
  Centers for Disease and Disease Control
  Prevention 2019, PCOS is one of the most common
  causes of female infertility, affecting 6 to 12
  (as many as 5 million) women of reproductive age
  in the U.S. Moreover, more than half of the women
  with PCOS develop type 2 diabetes by age 40.

11

• Clomiphene Citrate Market Regional Analysis
• Furthermore, Europe clomiphene citrate market is
  expected to gain traction in the near future,
  owing to various strategies implemented by the
  key players in the region. Key players are
  focused on providing reimbursements to patients
  to make the medicines available at affordable
  prices. For instance, Sanofi S.A. provides
  reimbursement for CLOMID under the Pharmaceutical
  Benefits Scheme (PBS) in Europe and Australia, in
  order to make the medicines available at
  affordable prices for patients. PBS provides
  timely, reliable, and affordable access to
  fertility medications to the people in Europe and
  Australia. The medicine is prescribed for the
  treatment of ovulatory failure in selected
  infertile women who wish to become pregnant.

12

• Figure 2 Clomiphene Citrate Market Value (US
  Mn) Y-o-Y Growth (), 2017-2027

13

• Clomiphene Citrate Market - Competitive Landscape
• Key players operating in the clomiphene citrate
  market include Sanofi S.A., Par Pharmaceutical,
  Merck Co. Inc., Teva Pharmaceutical Industries
  Ltd., Cipla Inc., Unichem Laboratories Ltd.,
  Emcure Pharmaceuticals Ltd., Serum Institute of
  India Pvt. Ltd., Incepta Pharmaceuticals Ltd.,
  and Shanghai Trifecta Pharma Co. Ltd.

14

• Request Sample Report
• Request Customization
• Download PDF Brochure
• Talk to Analyst
• Buy Now
• Reference https//www.coherentmarketinsights.com/
  market-insight/clomiphene-citrate-market-4140

15
About Us

• Coherent Market Insights is a global market
  intelligence and consulting organization focused
  on assisting our plethora of clients achieve
  transformational growth by helping them make
  critical business decisions.
• What we provide
• Customized Market Research Services
• Industry Analysis Services
• Business Consulting Services
• Market Intelligence Services
• Long term Engagement Model
• Country Specific Analysis

16
Contact Us

• Mr. Shah
• Coherent Market Insights Pvt.Ltd.
• Address 1001 4th Ave, 3200 Seattle, WA 98154,
  U.S.
• Phone [phone]
• Email sales_at_coherentmarketinsights.com

17

• Thank You!
• Kindly follow CMI Social Media
  Profiles for the latest company updates
• Facebook
• Linkedin
• Twitter
• https//www.coherentmarketinsights.com/